Literature DB >> 10846038

EP(2) receptor mediates bronchodilation by PGE(2) in mice.

J R Sheller1, D Mitchell, B Meyrick, J Oates, R Breyer.   

Abstract

PGE(2) is an important cyclooxygenase product that modulates airway inflammatory and smooth muscle responses. Signal transduction is mediated by four EP receptor subtypes that cause distinct effects on cell metabolism. To determine the role of EP(2) receptor activation, we produced a mouse lacking the EP(2) receptor by targeted gene disruption. The effect of aerosolized PGE(2) and other agonists was measured using barometric plethysmography and by measurements of lung resistance in mechanically ventilated mice. Inhalation of PGE(2) inhibited methacholine responses in wild-type but not in mice lacking the EP(2) receptor [EP(2)(-/-)]. After airway constriction was induced by methacholine aerosol, PGE(2) reduced the airway constriction enhanced pause in wild-type mice (from 0.88 +/- 0.15 to 0.55 +/- 0.06) but increased it in EP(2)(-/-) mice (from 0.73 +/- 0. 08 to 1.27 +/- 0.19). Similar results were obtained in mechanically ventilated mice. These data indicate that the EP(2) receptor mediates the bronchodilation effect of PGE(2).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10846038     DOI: 10.1152/jappl.2000.88.6.2214

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  22 in total

Review 1.  Genetic and pharmacological analysis of prostanoid receptor function.

Authors:  S Narumiya; G A FitzGerald
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

Review 2.  Embracing emerging paradigms of G protein-coupled receptor agonism and signaling to address airway smooth muscle pathobiology in asthma.

Authors:  Raymond B Penn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-02-16       Impact factor: 3.000

3.  Endogenous Gs-coupled receptors in smooth muscle exhibit differential susceptibility to GRK2/3-mediated desensitization.

Authors:  Kok Choi Kong; Uma Gandhi; T J Martin; Candace B Anz; Huandong Yan; Anna M Misior; Rodolfo M Pascual; Deepak A Deshpande; Raymond B Penn
Journal:  Biochemistry       Date:  2008-08-09       Impact factor: 3.162

4.  Cyclooxygenase-1 overexpression decreases Basal airway responsiveness but not allergic inflammation.

Authors:  Jeffrey W Card; Michelle A Carey; J Alyce Bradbury; Joan P Graves; Fred B Lih; Michael P Moorman; Daniel L Morgan; Laura M DeGraff; Yun Zhao; Julie F Foley; Darryl C Zeldin
Journal:  J Immunol       Date:  2006-10-01       Impact factor: 5.422

5.  Prostanoids and the cough reflex.

Authors:  Sarah A Maher; Maria G Belvisi
Journal:  Lung       Date:  2009-10-15       Impact factor: 2.584

6.  Rabbit plasma metabolomic analysis of Nitroproston®: a multi target natural prostaglandin based-drug.

Authors:  Ksenia Shestakova; Alex Brito; Natalia V Mesonzhnik; Natalia E Moskaleva; Ksenia O Kurynina; Natalia M Grestskaya; Igor V Serkov; Igor I Lyubimov; Vladimir V Bezuglov; Svetlana A Appolonova
Journal:  Metabolomics       Date:  2018-08-20       Impact factor: 4.290

Review 7.  Protease-activated receptors and prostaglandins in inflammatory lung disease.

Authors:  Terence Peters; Peter J Henry
Journal:  Br J Pharmacol       Date:  2009-10       Impact factor: 8.739

8.  International Union of Basic and Clinical Pharmacology. CIX. Differences and Similarities between Human and Rodent Prostaglandin E2 Receptors (EP1-4) and Prostacyclin Receptor (IP): Specific Roles in Pathophysiologic Conditions.

Authors:  Xavier Norel; Yukihiko Sugimoto; Gulsev Ozen; Heba Abdelazeem; Yasmine Amgoud; Amel Bouhadoun; Wesam Bassiouni; Marie Goepp; Salma Mani; Hasanga D Manikpurage; Amira Senbel; Dan Longrois; Akos Heinemann; Chengcan Yao; Lucie H Clapp
Journal:  Pharmacol Rev       Date:  2020-10       Impact factor: 25.468

Review 9.  Lipid mediators and allergic diseases.

Authors:  Laura B Fanning; Joshua A Boyce
Journal:  Ann Allergy Asthma Immunol       Date:  2013-07-21       Impact factor: 6.347

Review 10.  Prostaglandins in asthma and allergic diseases.

Authors:  R Stokes Peebles
Journal:  Pharmacol Ther       Date:  2018-08-03       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.